Lowe Nicholas J, Maxwell C Anne, Lowe Philippa, Shah Ardash, Patnaik Rickie
Cranley Clinic, London, United Kingdom.
Dermatol Surg. 2009 Feb;35 Suppl 1:344-9. doi: 10.1111/j.1524-4725.2008.01061.x.
Injectable poly-l-lactic acid (PLLA) has been used to correct age- or disease-related facial volume deficits.
This single-center, retrospective survey evaluated PLLA for cosmetic use.
A questionnaire was mailed to 281 patients treated with PLLA 6 months or more previously. PLLA was reconstituted 4 hours or more before injection with 5 mL of sterile water plus 1 mL of 1% xylocaine added before injection.
Two hundred twenty-one patients responded (210 female; average age 54.3; average treatments 3.3 per patient); the majority had received facial injections. Transient side effects included bruising, swelling, and discomfort. After treatment (1-6 months), 14/41 patients developed Grade 1 papules or nodules (slightly palpable, nonvisible; clinically nonrelevant; all resolved spontaneously), 15/41 developed Grade 2 papules or nodules (palpable, slightly visible; clinically nonrelevant; all resolved spontaneously), and 12/41 developed Grade 3 nodules (easily palpable, obviously visible [9 perioral; 3 periorbital or temple]; 5 resolved spontaneously; 7 were treated [5 intralesional corticosteroids; 2 surgery]).
Patients treated with PLLA experienced duration of improvement of up to 24 months. Maximum improvement took several treatment sessions. Nodules occurred in perioral and periorbital regions, so incidence is reduced by avoiding these areas.
可注射聚左旋乳酸(PLLA)已被用于矫正与年龄或疾病相关的面部容量不足。
这项单中心回顾性调查评估了PLLA的美容用途。
向281例6个月或更久之前接受PLLA治疗的患者邮寄了调查问卷。PLLA在注射前4小时或更长时间用5 mL无菌水复溶,并在注射前加入1 mL 1%利多卡因。
221例患者回复(210例女性;平均年龄54.3岁;每位患者平均治疗3.3次);大多数患者接受了面部注射。短暂的副作用包括瘀斑、肿胀和不适。治疗后(1 - 6个月),41例患者中有14例出现1级丘疹或结节(轻微可触及,不可见;临床无关紧要;均自发消退),41例中有15例出现2级丘疹或结节(可触及,轻微可见;临床无关紧要;均自发消退),41例中有12例出现3级结节(容易触及,明显可见[9例在口周;3例在眶周或颞部];5例自发消退;7例接受治疗[5例皮损内注射皮质类固醇;2例手术])。
接受PLLA治疗的患者改善持续时间长达24个月。最大改善需要几个疗程。结节出现在口周和眶周区域,因此通过避开这些区域可降低发生率。